Zobrazeno 1 - 10 of 41 pro vyhledávání: '"Ester Zylber-Katz"'
1
Strategies for Increasing Drug Delivery to the Brain
Autor: Ester Zylber-Katz, Tali Siegal
Publikováno v: Clinical Pharmacokinetics. 41:171-186
The blood-brain barrier (BBB) is a gate that controls the influx and efflux of a wide variety of substances and consequently restricts the delivery of drugs into the central nervous system (CNS). Brain tumours may disrupt the function of this barrier
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec0c0b9675a3ae32f53cd64c2a8b724
https://doi.org/10.2165/00003088-200241030-00002
Zobrazit plný text záznamu
2
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators
Autor: Yoseph Caraco, Micha Levy, Rifaat Safadi, Ester Zylber-Katz, L. Granit
Publikováno v: European Journal of Clinical Pharmacology. 57:461-465
Objective: We previously found that, compared with healthy subjects, asymptomatic hepatitis-B virus (HBV) carriers displaying slow acetylator phenotype demonstrate a significant prolongation of the elimination half-life of 4-methylaminoantipyrine (MA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8bf82f43913d252891b73a69d340071
https://doi.org/10.1007/s002280100341
Zobrazit plný text záznamu
3
Systemic absorption of lidocaine after topical application for the treatment of oral mucositis in bone marrow transplantation patients
Autor: Ester Zylber-Katz, Dan Galili, Adi A. Garfunkel, Moti Findler, Galit Cohen, Reuven Or, Sharon Elad
Publikováno v: Journal of Oral Pathology & Medicine. 28:170-172
This paper evaluates lidocaine absorption via oral mucosa following its topical application for symptomatic treatment of bone marrow transplantation (BMT)-induced oral mucositis. Five patients with high-grade oral mucositis after allogeneic BMT were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e239f565d628cfe3768c76bf8d0dd261
https://doi.org/10.1111/j.1600-0714.1999.tb02018.x
Zobrazit plný text záznamu
4
Cerebrospinal fluid prostaglandins after systemic dipyrone intake*
Autor: Kay Brune, Micha Levy, Ester Zylber-Katz, Yoseph Caraco, Gerd Geisslinger, Oren Cohen
Publikováno v: Clinical Pharmacology & Therapeutics. 64:117-122
Objective The object of this study was to evaluate the time course of thromboxane B2 and prostaglandin E2 concentrations in cerebrospinal fluid after oral administration of dipyrone (INN, metamizole). Methods A single 1.0 gm oral dose of dipyrone was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c306e0c1f2db4643982e9afa477179de
https://doi.org/10.1016/s0009-9236(98)90029-7
Zobrazit plný text záznamu
5
Digoxin Intoxication in a Patient With End-Stage Renal Disease
Autor: Olga Gotsman, Dana G. Wolf, Ester Zylber-Katz, Yoseph Caraco, Opher Caspi
Publikováno v: Therapeutic Drug Monitoring. 19:510-515
Digoxin intoxication is a serious medical problem, and impairment of renal function is a common risk factor for toxicity. Digoxin specific antibody fragments (Fab) is the most effective treatment available for severe digitalis intoxication. The use o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a87c612922ba035aa5f10e6f2fff08
https://doi.org/10.1097/00007691-199710000-00004
Zobrazit plný text záznamu
7
Carbamazepine Phakmacokinetics in Obese and Lean Subjects
Autor: Micha Levy, Ester Zylber-Katz, Elliot M Berry, Yoseph Caraco
Publikováno v: Annals of Pharmacotherapy. 29:843-847
Objective: To compare carbamazepine pharmacokinetic parameters between obese and lean subjects following the administration of a single 200-mg tablet. Design: Single-dose intervention, open study. Setting: Teaching university hospital. Subjects: Eigh
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a186ed42fb2e54d10ff8d700e2c6f52
https://doi.org/10.1177/106002809502900902
Zobrazit plný text záznamu
8
Dipyrone metabolism in liver disease*
Autor: L. Granit, Micha Levy, Yoseph Caraco, Ester Zylber-Katz
Publikováno v: Clinical Pharmacology & Therapeutics. 58:198-209
Background and objectives Dipyrone is an analgesic, antipyretic, and anti-inflammatory drug. After oral administration it is hydrolyzed to 4-methylaminoantipyrine and further metabolized to 4-aminoantipyrine, 4-formylaminoantipyrine, and 4-acetylamin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c989d3c69c6ef96a39129d25ffb7d8
https://doi.org/10.1016/0009-9236(95)90198-1
Zobrazit plný text záznamu
9
The Pharmacokinetics of the Dipyrone Product 4-Methylaminoantipyrine in Patients with Liver Cirrhosis
Autor: L. Granit, Micha Levy, Ester Zylber-Katz, Yoseph Caraco, A. Blum
Publikováno v: Drug Investigation. 4:219-226
Dipyrone (noramidopyrine methanesulphonate) is a drug with analgesic, antipyretic and anti-inflammatory properties. It is hydrolysed in the gastrointestinal tract to an active moiety, methylaminoantipyrine (MAA), which is subsequently absorbed. The p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::858ca57b11bbcb90fc98f7b15823e372
https://doi.org/10.1007/bf03258402
Zobrazit plný text záznamu
10
Formation and excretion of dipyrone metabolites in man
Autor: Micha Levy, Ester Zylber-Katz, L. Granit
Publikováno v: European Journal of Clinical Pharmacology. 42:187-191
The formation and urinary excretion of the dipyrone metabolites, methylaminoantipyrine (MAA), aminoantipyrine (AA), formylaminoantipyrine (FAA) and acetylaminoantipyrine (AAA) were determined following administration of a single oral 1.0 g dose of di
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f96055db12f14df1b409bb7f1669db
https://doi.org/10.1007/bf00278482
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje